The Role of Prion Protein in Reelin/Dab1 Signaling: Implications for Neurodegeneration
The cellular prion protein (PrP<sup>C</sup>) is studied in prion diseases, where its misfolded isoform (PrP<sup>Sc</sup>) leads to neurodegeneration. PrP<sup>C</sup> has also been implicated in several physiological functions. The protein is abundant in the nervou...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/7/928 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The cellular prion protein (PrP<sup>C</sup>) is studied in prion diseases, where its misfolded isoform (PrP<sup>Sc</sup>) leads to neurodegeneration. PrP<sup>C</sup> has also been implicated in several physiological functions. The protein is abundant in the nervous system, and it is critical for cell signaling in cellular communication, where it acts as a scaffold for various signaling molecules. The Reelin signaling pathway, implicated both in Alzheimer’s and prion diseases, engages Dab1, an adaptor protein influencing APP processing and amyloid beta deposition. Here, we show, using <i>Prnp</i> knockout models (<i>Prnp</i><sup>0/0</sup>), that PrP<sup>C</sup> modulates Reelin signaling, affecting Dab1 activation and downstream phosphorylation in both neuronal cultures and mouse brains. Notably, <i>Prnp</i><sup>0/0</sup> mice showed reduced responsiveness to Reelin, associated with altered Dab1 phosphorylation and Fyn kinase activity. Even though no direct interaction between PrP<sup>C</sup> and Reelin/ApoER2 was found, <i>Prnp</i><sup>0/0</sup> neurons showed lower NCAM levels, a well-established PrP<sup>C</sup> interactor. Prion infection further disrupted the Reelin signaling pathway, thus downregulating Dab1 and Reelin receptors and altering Reelin processing, like Alzheimer’s disease pathology. These findings emphasize PrP<sup>C</sup> indirect role in Dab1 signaling via the NCAM and Fyn pathways, which influence synaptic function and neurodegeneration in prion diseases. |
|---|---|
| ISSN: | 1999-4915 |